Duration : You can continue the medication for up to 13 days if needed
Additionally, patients should be advised to use sun protection while using this product, as some ingredients may increase the skin's sensitivity to sunlight
HS-20093, a TOPI inhibitor (HS-9265)-carrying ADC, was shown to have an acceptable safety profile and promising antitumor activity in a phase I study in patients with advanced solid tumors (NCT05276609), and is currently undergoing a phase II trial in mCRPC patients (NCT06001255) 106,107
Effective Communication with Your Healthcare Provider Clear and honest communication with your healthcare provider is key to managing lower back pain
Gently swirl or invert to mix
These conditions do not automatically preclude treatment, but they demand individualized risk assessment by a qualified healthcare provider before initiation